ROS1-Positive interim data raises Mara Goldstein’s conviction.
H.C. Wainwright analyst Ram Selvaraju was out pounding the table on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) …
The complete response letter: Antares and AcelRx have just gotten the kind of mail no one wants to receive.
Ardelyx’s drug tenapanor gets closer to FDA approval; Cantor’s Mara Goldstein weighs in.
Tenapanor is a viable drug in the treatment of IBS-C, says Cantor’s Mara Goldstein.
No surprises within Rhopressa briefing documents – Good news for Aerie investors.
Mannkind caught a price target boost from Maxim in the wake of a positive label revision for Afrezza.
BTIG feels confident in Vericel core business as ixmyelocel-T’s future became uncertain.
ACAD receives BTD in dementia-related psychosis; Initiates DRP phase 3 trial; Phase 2 SERENE trial discontinued.
Sarepta shares dropped 4% after patient deaths revealed in the FDA FAERS database.